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1
 The abbreviations used are: BSA, bovine serum albumin; BLI, biolayer interferometry; 
EHEC, enterohemorrhagic Escherichia coli; EPEC, enteropathogenic Escherichia coli; 
DMEM, Dulbecco’s modified Eagle’s medium; EDC, N-(3-Dimethylaminopropyl)-N’-
ethylcarbodiimide; EDTA, ethylenediaminetetracetic acid; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; GST, glutathione-S-transferase; IPTG, isopropyl--
thiogalactoside; LB, Luria-Bertani broth; LEE, locus of enterocyte effacement; MES, 2-(N-
morpholino)ethanesulfonic acid; NHS, N-hydroxysuccinimide ester; NTA, nitrilotriacetic 
acid; PVDF, polyvinylidene difluoride; SDS-PAGE, sodium dodecyl sulphate-
polyacrylamide gel electrophoresis; TCA, trichloroacetic acid; T3SS, type III secretion 
system. 
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Abstract  
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a multifunctional 
housekeeping protein secreted by pathogens and involved in adhesion and/or virulence. 
Previously we reported that enterohemorragic (EHEC) and enteropathogenic (EPEC) 
Escherichia coli secrete GAPDH into the culture medium. This bacterial protein binds 
human plasminogen and fibrinogen and remains associated with Caco-2 cells upon 
infection. In these pathogens, GAPDH secretion is not linked to outer membrane vesicles 
and depends on growth conditions, although the secretion mechanism is still unknown. 
EPEC is an attaching and effacing pathogen able to secrete and translocate multiple effector 
proteins into infected cells through a type III secretion system (T3SS). The secretion 
process is often dependent on a bacterial chaperone. The chaperone CesT displays broad 
substrate specificity and plays a central role in the recruitment of multiple type III effectors 
to the T3SS apparatus. Here we provide genetic evidences on GAPDH secretion through 
T3SS by EPEC grown in DMEM. Secretion of GAPDH is increased in sepD mutants and 
abolished in mutants defective in the type III ATPase EscN. Complementation with escN 
gene restores GAPDH secretion. In addition, we prove by means of pull down experiments, 
overlay immunoblotting and biolayer interferometry a novel interaction between GAPDH 
and the chaperone CesT. This interaction, which is strong and slow dissociating, may 
stabilise a population of GAPDH molecules in a secretion competent-state and target them 
to the type III secretion apparatus. This is the first description of CesT interaction with a 
housekeeping protein and its export through T3SS.  
Key words: glyceraldehyde-3-phosphate dehydrogenase, protein secretion, T3SS effector, 
chaperone CesT, Escherichia coli
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1. Introduction  
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, EC 1.2.1.12), a key enzyme in 
the glycolytic pathway, is considered a multifunctional protein involved in numerous 
cellular processes in mammalian cells (reviewed in Sirover, 2005, 2011). In bacteria, non-
glycolytic GAPDH functions have been associated with its extracellular location. GAPDH 
is one of the housekeeping proteins secreted by pathogens that interact with different host 
components, being involved in adhesion and/or virulence (Alvarez-Dominguez et al., 2008; 
Jin et al., 2005; Lama et al., 2009; Pancholi and Chhatwal, 2003; Schaumburg et al., 2004; 
Seifert et al., 2003;  Terao et al., 2006).  
In gram-negative pathogens, GAPDH was shown to be secreted into the medium in a 
soluble and active form by enterohemorragic Escherichia coli (EHEC) and 
enteropathogenic E. coli (EPEC). In these pathogens, secretion is not linked to outer 
membrane vesicles and depends on growth conditions. The protein is secreted at 37°C by 
cells grown in LB or in eukaryotic culture media such as DMEM or Ham's F-12, but not in 
glucose-minimal medium (Egea et al., 2007). E. coli GAPDH binds human plasminogen 
and fibrinogen and remains associated with Caco-2 cells upon infection (Egea et al., 2007). 
In addition, we have shown that the secreted protein can act as a target of oxidation and 
may therefore protect bacteria against host oxidative response (Aguilera et al., 2009).  
Although descriptions of GAPDH on the surface of gram-positive bacteria or yeast 
can be traced back more than 15 years, the mechanism that directs its secretion is still 
unknown. In gram-negative bacteria eight major protein secretion systems have been 
described so far and named from T1SS to T8SS (Desvaux et al., 2009). The type III 
secretion system (T3SS) is a key determinant of virulence in many gram-negative bacteria, 
including animal and plant pathogens. T3SS is a complex protein export apparatus 
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composed of a multi-ring base, an inner rod and a protruding needle, which facilitates direct 
delivery of bacterial virulence proteins (effectors) into host cells (Izoré et al., 2011; 
Marlovits et al., 2006). T3SS effectors play important roles in infection by modulating or 
disrupting cellular structures and functions or host immune responses (reviewed by Dean 
and Kenny, 2009). 
EPEC and EHEC are members of a closely related family that intimately attach to 
intestinal epithelial cells and induce characteristic attaching and effacing (A/E) lesions on 
the host cell, causing diarrhea (Dean et al., 2005; Kaper et al., 2004). The A/E phenotype 
consists of the loss of microvilli and the accumulation of actin filaments and other 
cytoskeletal proteins beneath adherent bacteria. In EPEC, the ability to induce the A/E 
effects is encoded in a 41-gene pathogenicity island, called the locus of enterocyte 
effacement (LEE) (MacDaniel and Kaper, 1997). The components of the type III secretion 
system are encoded in this locus together with associated transcriptional regulators, 
chaperones and effector proteins.  
A large number of proteins are secreted by T3SS into culture media (Deng et al., 
2010). These protein substrates can be divided in several categories based on their secretion 
hierarchy. Early substrates are components of the needle and inner rod. The needle complex 
secretes the LEE-encoded translocators EspA, EspB and EspD (intermediate substrates) 
before the effectors (late substrates). Translocators are needed for translocation of the 
effectors into host cells (Luo and Donnenberg, 2006). To date multiple type III effectors 
have been identified in EPEC, some of them are encoded within the LEE whereas others 
are encoded in distinct pathogenicity islands through the chromosome (reviewed by Dean 
and Kenny, 2009). The secretion hierarchy of translocators and effectors is regulated by 
SepL and SepD (Deng et al., 2005; O’Connell et al., 2004).  
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Type III effectors from many pathogens usually have an associated chaperone that is 
not secreted (class I chaperones) (Izoré et al., 2011; Parsot et al., 2003). These chaperones 
are generally small soluble proteins (15-20 kDa) with an acidic pI that form homodimers 
that bind to the amino-terminal region of effectors and remain in the bacterial cell after 
translocation of the effectors into the host cell. However, in many cases, chaperones are not 
absolutely required for effector secretion (Parsot et al., 2003). Chaperone-effector 
interactions occur mainly between secondary structured elements of the effector and 
hydrophobic patches present on the chaperone dimer (Parsot et al., 2003). Multiples roles 
have been attributed to these chaperones such as substrate stabilization, prevention of 
substrate premature interactions with other partners in the bacterial cytoplasm or regulation 
of virulence gene expression (Page and Parsot, 2002).  
In EPEC, the LEE-encoded chaperone CesT was shown to interact with several type 
III effectors encoded within and outside the LEE pathogenicity island (Thomas et al., 2005; 
Thomas et al., 2007).  Through its interaction with the type III ATPase EscN, CesT 
promotes the recruitment of the cognate effectors to the T3SS apparatus for efficient 
secretion (Thomas et al., 2005).  
Here we report that T3SS mediates GAPDH secretion in EPEC cells grown in DMEM 
and provide experimental evidence on a novel interaction between GAPDH and the general 
T3SS chaperone CesT. This interaction may stabilise a small population of GAPDH 
molecules in a secretion competent-state and target them to the type III secretion apparatus. 
This is the first description on CesT interaction with a housekeeping protein and its export 
through T3SS.  
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2. Materials and Methods 
 
2.1. Bacterial strains and growth conditions.   
E.coli strains and plasmids used in this study are listed in Table 1. Bacterial cells were 
routinely grown at 37ºC in Luria-Bertani broth (LB). Where indicated cells were grown 
without shaking at 37ºC in LB or Dulbecco’s modified Eagle’s medium (DMEM) in a CO2 
incubator. Growth was monitored by measuring the optical density at 600 nm (OD600). 
When indicated, 5 mM IPTG was added to the medium as inducer of chromosome 
encoded-lacZ expression. When required, ampicillin (100 g/ml) or kanamycin (50 g/ml) 
was added to the medium. 
 
2.2. Protein secretion assays.  
Isolation of secreted proteins was performed as previously described (Egea et al., 
2007). Briefly, overnight cultures in LB were diluted 1:50 in the indicated culture media 
and incubated without shaking at 37ºC in a 5% CO2 atmosphere. After 6-8 h of growth 
(OD600 of 0.8) bacteria were collected by centrifugation (5,000 x g, 10 min, 4º C), and the 
supernatant was passed through a 0.22 m-pore-size filter (Millipore). The proteins in the 
filtrate were precipitated by incubation on ice for at least 1 h with 10% trichloroacetic acid 
(TCA). When indicated, 0.1% bovine serum albumin (BSA) was added to the filtered 
supernatant before TCA precipitation. The protein pellet was washed in 90% (v/v) ice-cold 
acetone, air-dried and suspended in loading buffer before being resolved by SDS-PAGE 
(Laemmli, 1970). Collected bacteria were resuspended in loading buffer and kept for SDS-
PAGE analysis.  
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2.3. DNA manipulation.  
Bacterial genomic DNA was obtained using the Wizard Genomic DNA purification 
kit (Promega), and plasmid DNA was prepared using the Wizard Plus SV Midipreps DNA 
purification system (Promega). DNA manipulations in vitro were performed according to 
standard protocols (Sambrook and Rusell, 2001). DNA fragments were amplified by PCR 
using chromosomal DNA as template. When necessary, specific restriction sites were 
incorporated at the 5'-end of the primers to facilitate the cloning of the fragments in the 
appropriate vector. PCR reactions were performed with Pfu DNA polymerase in standard 
conditions. DNA was sequenced using an automated ABI 377 DNA sequencer and 
fluorescent dye termination methods.  
To obtain a plasmid construct expressing His6-CesT, the cesT gene was amplified by 
PCR using EPEC E2348/69 genomic DNA and primers CesT-pQE30-bam.fw (5’-CGC-
GGATCCATGTCATCAAGATCTGAAC-3’) and CesT-pQE30-hind.rv (5’-CGC-
AAGCTTTTATCTTCCGGCGTAATAATG-3’) and cloned into BamHI/HindIII digested 
plasmid pQE30 (Qiagen), yielding pQE-CesT. Restriction sites incorporated at the 5’end of 
the primers are underlined. The forward primer was designed to fuse the His6-tag in frame 
with cesT. Plasmid DNA was sequenced to ensure that no mutations have been introduced 
during the amplification reaction. 
 
2.4. Pull-down experiments with His6-CesT.  
Overproduction of His6-tagged CesT was achieved in transformed cells of strain M15 
[pREP4] bearing the recombinant plasmid pQE-CesT after isopropyl--thiogalactoside 
(IPTG) induction (0.3 mM) in LB-ampicillin-kanamycin medium for 16 h at 37 °C. The 
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protein was purifed under native conditions with Ni
2+
-nitrilotriacetic acid (NTA) resin 
(Qiagen). Centrifugations were performed at 4 °C, and column chromatography was carried 
out at room temperature. The cell pellet from a 15 ml culture of strain M15 [pREP4] 
bearing plasmid pQE-CesT was suspended in 1 ml of 50 mM sodium phosphate buffer, pH 
8.0, containing 10 mM imidazole and 300 mM NaCl (binding buffer), and sonicated on ice. 
The cell lysate was centrifuged at 15000 g, and the supernatant was incubated with 0.1 ml 
of Ni
2+
-NTA resin for 1 h at 4ºC with gentle shaking. After loading the mixture into a 
column, the resin was washed with 50 mM sodium phosphate buffer, pH 8.0, containing 20 
mM imidazole and 300 mM NaCl (wash buffer). 
 Column-bound His6-CesT was equilibrated with binding buffer, followed by the 
addition of 0.5 ml of an EPEC cell extract (10 mg/ml) in binding buffer obtained from cells 
grown in DMEM by sonic disruption as described above. The flow-through fraction was 
kept for analysis. The column was washed 4 x 5 ml of wash buffer. A last 0.1ml wash was 
performed and kept for gel analysis. Recombinant His6-CesT and interacting proteins were 
then eluted with 0.1 ml of elution buffer (50 mM sodium phosphate buffer, pH 8.0, 
containing 300 mM imidazole and 300 mM NaCl) followed by SDS-PAGE and 
immunoblotting analysis.  
 
2.5. Immunoblotting analysis.  
For Western blot analysis, protein samples were separated on 10% SDS-PAGE and 
transferred to a HyBond-P polyvinylidene difluoride (PVDF) membrane by using a Bio-
Rad MiniTransblot apparatus. Equal numbers of bacteria were used to prepare samples 
(whole cell lysates or secreted proteins) for analysis. The membrane was blocked in PBS-
0.05% Tween-20 and 5% skimmed milk (blocking solution) for 1 h at room temperature, 
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and then incubated with specific antibodies against GAPDH (1:5,000 dilution in blocking 
solution) (Egea et al., 2007) or with antibodies against -galactosidase (Abcam, 1:10,000 
dilution) for 16 h at 4°C. The secondary antibody was donkey anti-rabbit immunoglobulin 
horseradish peroxidase-linked, diluted 1:15,000 in blocking solution. Incubation with the 
secondary antibody was omitted when anti-His horseradish peroxidase-linked antibody 
(GenScript; 1:5,000 dilution) was used as primary antibody. The protein-antibody complex 
was visualized by using the ECL Plus Western blotting detection system (Amersham 
Pharmacia Biotech). Control gels were stained with Sypro® Ruby or Coomassie Brilliant 
Blue R-250.  
Binding of GAPDH to CesT was analyzed by Far-Western assays (overlay 
immunoblotting). For these experiments recombinant GAPDH was expressed and purified 
using the Glutathione-S-transferase (GST) gene fusion system with recognition sites for 
factor Xa cleavage as described in detail previously (Egea et al., 2007). Purified GAPDH 
was further purified by affinity chromatography with anti-factor Xa-agarose resin (Sigma) 
to remove factor Xa. 
For mono-dimensional Far-Western experiments, purified GAPDH (2.5 g) was 
separated on 10% SDS-PAGE and transferred to a PVDF membrane. After being blocked 
overnight with 1% gelatin in TBS buffer (20 mM Tris-HCl, 150 mM NaCl , pH 7.6), the 
membrane was incubated with purified His6-CesT (1 or 5 g/ml) diluted in TBS-0.05% 
Tween-20 for 3 hours and then washed four times in the same buffer. To visualize 
interaction of GAPDH with CesT, the membrane was incubated with anti-His specific 
antibodies (1:5,000 dilution TBS-1% gelatin-0.05% Tween-20) for 16 h at 4ºC, and 
processed as described above using the ECL Western blotting kit to visualize the reactive 
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spots. The incubation step with purified His6-CesT was omitted as negative control. When 
indicated, purified GAPDH (5 g) was subjected to two-dimensional gel electrophoresis 
before being blotted onto the PVDF membrane, which was then incubated with purified 
His6-CesT (1 g/ml) and processed as described above. 
 
2.6. Two-dimensional gel electrophoresis.  
2D gel electrophoresis was performed using the Protean IEF-Cell (Bio-Rad). Purified 
recombinant GAPDH (5 g) was diluted in 125 l of rehydration buffer (9 M urea, 4% 
CHAPS, 50 mM dithiothreitol, 0.5% immobilized pH gradient buffer and traces of 
bromophenol blue). Isoelectric focusing was performed in immobilized pH 5-8 gradient 
strips (BioRad). Second dimension SDS-PAGE was performed on 12.5% acrylamide gels 
that were processed for immunoblotting analysis. Parallel gels were silver-stained to 
visualize total protein. 
 
2.7. Biolayer interferometry.  
Octet Red (Fortebio) instrument with amine reactive biosensors was used to study 
kinetics of GAPDH – CesT interaction. Carboxylic groups on the sensor surface were 
activated by incubation with 0.2 M [N-(3-Dimethylaminopropyl)-N’-ethylcarbodiimide] 
(EDC):0.05 M [N-hydroxysuccinimide ester] (NHS) during 10 min. The ligand CesT 
diluted in MES buffer pH 4.0 (final concentration of 50 g/ml) was then loaded on 
activated biosensors (10 min incubation). The unreacted NHS-esters were quenched with 
0.05 M ethanolamine for 10 min. All experiments were conducted at 30ºC with agitation set 
to 1000 rpm in 10 mM HEPES pH 7.5, 150 mM NaCl, 3 mM EDTA, 0.01% (w/v) Tween-
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20 and 0.1 mg/ml BSA. Biosensors with immobilized CesT were exposed to different 
concentrations of purified GAPDH (0–5.5 M). After dipping the biosensor with each 
concentration of the analyte GAPDH, the surface was regenerated with 0.1% SDS during 
30 seconds. This allowed it to return at the baseline. Data analysis and curve fitting were 
done using the ForteBio Data Analysis software version 6.3 provided by the manufacturer. 
Kinetic constants were obtained by fitting data to a 1:1 model after parallel reference sensor 
subtraction.  
 
 
3. Results and discussion 
 
 
3.1. GAPDH secretion through the LEE-encoded T3SS in EPEC.  
Secretion of GAPDH by EPEC in culture media known to induce the expression of 
LEE-encoded genes (Egea et al., 2007) prompted us to examine whether the LEE-encoded 
T3SS is involved in GAPDH secretion in this pathogen. To this end, GAPDH secretion was 
analyzed in escN or espB mutant strains. It is well known that mutations in escN, the gene 
encoding the T3SS ATPase, abolish secretion of both translocator and effector proteins 
through this system. In contrast, mutations in espB, the gene encoding a hydrophobic 
translocon protein that is thought to form with EspD a translocation pore through the host 
membrane, disrupt translocation of effector proteins into host cells during infection but do 
not impair secretion of these proteins into the extracellular medium (Deng et al., 2004, Luo 
and Donnenberg, 2006, Luo and Donenberg, 2011).  
Cells of wild-type EPEC E2348/69 and the derived mutant strains CVD452 
(escN::aphA3) and UMD864 (espB) were grown statically at 37ºC in DMEM or LB (a 
medium that promotes down-regulation of LEE-encoded T3SS) to an OD600 of 0.8. When 
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indicated, cultures were incubated overnight. Proteins in the cell-free culture supernatants 
were collected by TCA precipitation and the presence of secreted GAPDH in these 
fractions was analyzed by Western blot. To rule out cytosolic contamination due to cell 
lysis, immunoblots were revealed with antibodies against the intracellular protein -
galactosidase (Fig. 1). Expression of -galactosidase was achieved by addition of 5 mM 
IPTG to the culture medium. Gels run in parallel were stained with Sypro® Ruby to 
visualize total secreted protein.  
In cells grown in LB, no significant changes in the secretion profiles of the three 
strains were observed (Fig. 1A). In these growth conditions GAPDH was secreted by all 
strains at the same extent. The absence of -galactosidase in culture supernatants ruled out 
cell lysis phenomena, and indeed proves GAPDH secretion by LB-grown EPEC through a 
non-dependent T3SS mechanism. 
Regarding DMEM-cultured cells, as expected from the mutant phenotypes, the 
secretion profiles of wild-type EPEC and espB mutant were very similar, except for the 34 
kDa-protein band (EspB) that is absent from the UMD864 cell-free supernatant. The 
secretion profile was clearly different for the escN mutant. In this case, almost no secreted 
proteins were apparent in cell-free supernatants (Fig. 1A). The espB mutant UMD864 
displayed reduced GAPDH secretion in DMEM compared with the wild-type strain. In this 
mutant, GAPDH was immunodetected in supernatants of overnight DMEM cultures (Fig. 
1A). In contrast, secretion of GAPDH was completely abolished in the escN insertion 
mutant CVD452 grown in DMEM at any incubation time (Fig. 1A). The lack of GAPDH 
secretion in EPEC cells defective in the T3SS ATPase was confirmed with a non-polar 
escN mutant (Gauthier and Finlay, 2003) (Fig. 1B). To normalize protein precipitation 
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efficiency, TCA precipitation of cell free-supernatants was also performed in the presence 
of 0.1% BSA as a carrier.  Immunoblotting analysis also failed to detect secreted GAPDH 
in both escN mutants in these conditions (not shown). GAPDH secretion was restored in the 
escN mutants by plasmid pCVD446 bearing the wild-type escN gene (Fig. 1B). Overall, 
these results indicate that GAPDH may be secreted by the LEE-encoded T3SS in EPEC 
grown in DMEM.  
In EPEC cells defective in SepD function, the secretion of type III translocon 
components is reduced while the T3SS-dependent secretion of several effectors is highly 
increased, hence aiding the identification of previously unrecognized type III secreted 
proteins (Deng et al., 2004, 2005, O’Connell et al., 2004). Therefore, we set out to evaluate 
GAPDH secretion in DMEM cultures of a sepD mutant strain (Deng et al., 2005). Equal 
numbers of bacteria were used to obtain the secreted proteins for Western blot analysis. As 
shown in Fig.1C, GAPDH secretion was enhanced in the sepD mutant when compared 
with the wild-type strain.   
Results obtained with the espB, escN and sepD mutants show that GAPDH secretion 
profile follows that of the bona fide T3SS effectors thereby pointing to GAPDH as a 
putative type III effector protein in EPEC. 
 
3.2. Interaction of GAPDH with the general type III chaperone CesT.  
Although CesT was first described as a specific chaperone for the type III effectors 
Tir and Map, Thomas et al. (2005, 2007) showed, through an elegant work, that CesT is 
required for efficient secretion of many other type III effectors, some of them not encoded 
in the LEE pathogenicity island. We therefore set out to evaluate whether CesT can bind 
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GAPDH. To this end, His-tagged CesT was purified and bound to a Ni
2+
-NTA column 
followed by the addition of wild-type EPEC cell extract (0.5 ml; 10 mg/ml) in binding 
buffer obtained from cultures grown in DMEM. In this experiment, proteins that interact 
with CesT are retained on the column and then can be co-eluted with CesT. After extensive 
washing, His6-CesT was eluted with elution buffer. The purification fractions were then 
subjected to SDS-PAGE followed by Western blot analysis with antibodies against 
GAPDH. Parallel samples were revealed by Coomassie blue staining. As shown in Fig. 2 
the final wash fraction did not contain any detectable protein. In the eluted fraction, in 
addition to the dominant protein His6-CesT, other proteins were visible. These proteins may 
correspond to EPEC effectors interacting with CesT (Thomas et al., 2005). Immunoblotting 
of the column fractions with anti-GAPDH antibodies indicated that a fraction of this protein 
was bound and co-eluted with His6-CesT (Fig. 2, left panel). In a control experiment, the 
EPEC cell extract was directly applied to the Ni
2+
-NTA column and processed in parallel. 
Immunoblotting of the eluted fraction showed that the Ni
2+
-NTA resin did not bind 
GAPDH to any extent (Fig. 2, right panel).  
Since some type III efectors such as Tir directly bind EscN (Gauthier and Finley, 
2003), and this ATPase binds CesT, we set out to examine whether the observed GAPDH-
CesT interaction was dependent on EscN. Thus, the CesT column binding experiment was 
also performed with escN cell extracts obtained from DMEM cultures (Fig. 2, middle 
panel). Immunoblotting of the eluted fractions with anti-GAPDH antibodies revealed that 
GAPDH was bound on the column and co-eluted with His6-CesT, thus indicating that EscN 
is not necessary for CesT and GAPDH interaction. Retention of GAPDH on the CesT-
affinity column was also observed with cell extracts of the laboratory strain E.coli 
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M15[pREP4]. This result indicates that GAPDH interaction with CesT cannot be attributed 
to other bridging T3SS proteins and suggests direct GAPDH-CesT interaction.  
Direct binding of GAPDH to CesT was confirmed by mono-dimensional Far-Western 
assays in which purified GAPDH was subjected to SDS-PAGE, transferred to PVDF 
membrane and reacted with soluble purified His6-CesT (Fig. 3A). Since GAPDH is a target 
of multiple post-translational modifications we set out to analyze whether CesT binding 
activity is specifically linked to one of these forms. This was approached by Far-Western 
experiments, in which purified GAPDH was subjected to two-dimensional gel 
electrophoresis. Purified GAPDH yielded several spots that interacted with CesT (Fig. 3B), 
thus providing evidence that this binding is not strictly dependent on a GAPDH form.  
 The dissociation constants of GAPDH-CesT interaction were measured by biolayer 
interferometry (BLI), a technique that quantitates molecular interactions and provides the 
on/off rates. When we immobilized CesT and measured the affinity of the GAPDH-CesT 
complex (Fig. S1, supplemental material), we obtained a KD of 560 nM and a dissociation 
rate (koff) of the complex of 0.0015 s
–1
. Saturation kinetics with GAPDH could not be 
observed because only a minor fraction of GAPDH, presumably monomeric, was 
competent for CesT binding. The reverse experiment could not be performed because 
immobilization of GAPDH using amine chemistry led to the inactivation of GAPDH-CesT 
binding motifs. 
Even though the structural basis for GAPDH–CesT interaction is not yet known 
(nor is there a structure of CesT in complex with any of its effector proteins), the 
requirements for class I chaperone binding are likely to play important roles in shaping the 
interaction with GAPDH. In particular, the putative degenerate CesT-interacting amino-
terminal domain proposed for type III effectors of EPEC (Thomas et al., 2007) spans a 
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stretch of 60–120 amino acids. If the GAPDH–CesT interaction surface resembles the 
extended complexes described for analogous chaperone–effector interactions, such as SicP–
SptP (35–139) (PDB ID: 1JYO) (Stebbins and Galán, 2001) and SycE–YopE (17–85) 
(PDB ID: 1L2W) (Birtalan et al., 2002) (Fig. 4A), the 120 N-terminal amino-acid residues 
of GAPDH could adopt a similarly extended conformation to bind the four canonical 
hydrophobic patches exposed across the chaperone dimer. Indeed, the secondary structure 
and the pattern of conserved hydrophobic and positively charged residues that are thought 
to mediate the interaction of T3SS effectors and their cognate chaperones are discernable, 
despite considerable degeneracy, along the GAPDH amino terminus (Fig. 4B). Since the 
nascent, monomeric chain of GAPDH has been shown to interact with various chaperones 
and chaperonins as it emerges from the ribosome, like Trigger factor (Liu et al., 2010) and 
GroEL/GroES (Houry et al., 1999), it becomes plausible for CesT to compete for a small 
fraction of nascent GAPDH amino termini thereby interfering with its intracellular 
stabilization and folding, and targeting GAPDH instead for T3SS-mediated secretion, with 
proper folding and oligomerization taking place after translocation. The engagement of the 
GAPDH N-terminal segment in the interaction with CesT would imply the partial 
disruption of the GAPDH tetramer, since residues 41–51 contribute to the stabilization of 
the oligomerization interface (Fig. 4C). This would be in keeping with the proposal that 
proteins targeted for secretion via T3SS should translocate in an unfolded, or partially 
folded, non-globular state through the 25–Å-wide inner diameter of the needle complex 
(Stebbins and Galán, 2003). Taken together, these results indicate that a stable complex 
exists between the T3SS chaperone CesT and a particular GAPDH conformation, thereby 
providing a solid experimental underpinning for the redirection of a fraction of cytosolic 
GAPDH through the T3SS secretion system. 
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To analyze whether CesT function is essential for GAPDH secretion, immunoblotting 
experiments were performed with cell-free supernatants of DMEM cultures of a cesT 
mutant strain (Abe et al., 1999). Equal numbers of bacteria (wild type EPEC and the cesT 
mutant) were used to obtain secreted proteins for analysis. As shown in Fig.1C, GAPDH 
secretion was not abolished but reduced in the cesT mutant. The fact that the cognate 
chaperone is not absolutely required for protein secretion seems to be rather common for 
type III effectors in several pathogens (Parsot et al., 2003). Actually, there is evidence that 
Tir secretion is not strictly dependent on CesT as low levels of Tir can be detected in 
culture supernatants of cesT mutants (Elliot et al., 1999).  
This study describes for the first time the interaction of a housekeeping protein with 
the type III chaperone CesT. Interaction of GAPDH with this chaperone may provide the 
way by which GAPDH is targeted to the type III secretion apparatus and reinforce the idea 
that GAPDH is secreted by the LEE-encoded T3SS in EPEC cells grown in DMEM.  
 
3.3. A T3SS-independent GAPDH secretion pathway is operative in EPEC and probiotic E. 
coli strains grown in LB.   
Immunodetection of GAPDH in cell-free supernatants of the escN mutant strain 
CVD452 grown in LB (Fig. 1) indicated that a secretion system other than T3SS is 
responsible for GAPDH secretion in EPEC grown in this rich bacteriological medium. At 
this point we set out to study whether this alternative secretion system may also be active in 
non-pathogenic E. coli strains. In fact, in the last years several reports describe GAPDH 
secretion by some gram-positive probiotic strains of the genus Lactobacillus (Hurmalainen 
et al., 2007; Sanchez et al., 2008, 2009a, 2009b). Thus, we decided to analyze GAPDH 
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secretion in cultures of some gut microbiota E. coli strains: (i) strains isolated from stool of 
healthy people (EcoR12, EcoR26 and EcoR42) available from the Selander collection 
(Ochman and Selander, 1984) and (ii) the probiotic E. coli strain Nissle 1917 (serotype
 
O6:K5:H1). These bacterial cells were grown statically at 37ºC in DMEM or LB to an 
OD600 of 0.8. Presence of secreted GAPDH in the culture supernatants was analyzed by 
Western blot. None of the strains analyzed secreted GAPDH when grown in DMEM (Fig. 
5). These strains do not contain in their chromosome the T3SS-encoding genes. Therefore, 
this result is in accordance with the involvement of the LEE-encoded T3SS in GAPDH 
secretion in EPEC grown in DMEM. In contrast, great differences in GAPDH secretion 
among strains were observed in LB cultures. Extracellular GAPDH was detected in the 
supernatant of the probiotic strain Nisssle 1917, but not in the supernatants of the natural 
isolates EcoR26 (Fig. 5), EcoR12 and EcoR41 (not shown). These results indicate that the 
secretion mechanism responsible for GAPDH export in LB is active in both pathogenic and 
probiotic E. coli strains. It may be hypothesized that GAPDH secretion may confer to these 
strains an advantage in the context of gut colonization with respect to other components of 
the intestinal microbiota. In fact, GAPDH secretion and its interaction with extracellular 
host components such as mucin or extracellular matrix proteins are rather common among 
diverse pathogens and probiotic microorganisms (Hurmalainen et al., 2007; Kinoshita et al., 
2008; Lama et al., 2009; Pancholi and Chhatwal, 2003).  
Results presented in this study indeed prove that secretion of GAPDH in EPEC is 
mediated by at least two alternative pathways depending on the growth conditions: (i) the 
pathogen specific T3SS in cells grown in DMEM, and (ii) a system not yet identified in 
cells grown in LB, which is not restricted to pathogens but also operative in probiotic E. 
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coli strains. The widespread presence of multiple GAPDH secretion pathways is compatible 
with GAPDH roles in colonization and infection processes.   
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Figure Legends 
Fig. 1. Immunoblot analysis of GAPDH secretion by T3SS mutant derivatives of EPEC 
E23448/69. (A) The mutant strains UMD864 (espB), CVD452 (escN::aphA3) and the 
parental wild-type strain EPEC E23448/69 were grown statically in LB or DMEM to an 
OD600 of 0.8 (6-8 hours).When indicated cultures were grown overnight (o/n).  IPTG was 
added at 5 mM concentration to induce lacZ expression. Aliquots of the culture 
supernatants (SN) were precipitated with TCA and analyzed by Western blot using anti-
GAPDH specific antibodies, or anti--galactosidase as a control of cytosolic contamination. 
Parallel gels were stained with Sypro® Ruby to visualize total secreted protein. An 
arrowhead next to the molecular mass marker indicates the position of GAPDH (35 kDa).  
Whole cell lysates (WL) were prepared from the same samples and analyzed with the 
indicated antibodies. (B) Complementation of escN with plasmid pCVD446 expressing 
EscN. Cell-free supernatants from exponentially grown DMEM cultures (OD600 of 0.8) 
were precipitated with TCA and analyzed by Western blot using anti-GAPDH or anti--
galactosidase specific antibodies. (C) GAPDH secretion profile of sepD and cesT 
mutants compared with wild-type EPEC.  Supernatants were collected from exponentially 
grown DMEM cultures (OD600 of 0.8) and processed as described above. Equal numbers of 
bacteria were used to prepare samples for analysis. 
 
Fig. 2. Pull-down experiments showing binding of GAPDH to CesT. Cell extracts obtained 
from wild-type strain EPEC E23448/69 (left panel) or from the escN mutant strain CVD452 
(middle panel) grown in DMEM were passed over Ni-NTA column immobilized His6-cesT. 
Column fractions were analyzed either by Western blot with anti-GAPDH antibodies or by 
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Coomassie blue staining. An arrowhead next to the molecular mass marker indicates the 
position of GAPDH (35 kDa). As a control, the EPEC cell extract was directly applied to 
the Ni-NTA column and processed in parallel (right panel). CE, cell extract; FT, flow-
trough; W, final wash; E, eluted fraction. 
 
Fig. 3. Far-Western analysis of binding of soluble CesT to PVDF-immobilized GAPDH.  
(A) Mono-dimensional Far-Western analysis. Samples containing 2.5 g protein (purified 
His6-CesT or GAPDH) were subjected to 10% SDS-PAGE, and the gel was either 
Coomassie blue-stained or electroblotted. The PVDF membrane was reacted with 
recombinant His6-CesT (1 g/ml or 5 g/ml), subsequently incubated with antibodies anti-
His horseradish peroxidase-linked antibody and processed to visualize the reactive bands.  
As a control, the panel labelled as (-) shows the result of this analysis when the incubation 
step with purified His6-CesT was omitted. (B) Bi-dimemsional Far-Western analysis. 
Samples containing 5 g of purified GAPDH were subjected to two-dimensional gel 
electrophoresis and the gel was either silver-stained (first panel) or electroblotted. The 
PVDF membrane was reacted with purified His6-CesT (5 g/ml), subsequently incubated 
with antibodies anti-His and processed to visualize the reactive bands (second panel).  The 
third panel shows the result of this analysis when the incubation step with recombinant 
CesT was omitted. 
 
Fig. 4.  Structural requirements for CesT–GAPDH interaction.  (A) Cartoon representation 
of the YopE–SycE (PDB ID: 1L2W) and SicP–SptT (PDB ID: 1JYO) crystal structures 
shown in two views related by a 90º rotation around a horizontal axis. Chaperones (SycE 
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and SicP) are coloured in grey surrounded by their semi-transparent molecular surface and 
effectors (YopE and SptP) in light orange. Side chains in sticks (CPK colours) correspond 
to amino acid residues relevant for the chaperone–effector interaction; in particular, a 
conserved glutamic acid residue on the chaperones (E115 and E118) and the effector -
strands (and preceding conserved arginine/lysine residues) and central -helix (and 
preceding conserved aspartic acid), are highlighted. (B) Annotated amino terminal 
sequences of YopE and SptP effector proteins and E. coli GAPDH (GapA) starting at 
residues 28, 47, and 23, respectively, with the experimentally determined secondary 
structure underneath (H = -helix; E = extended -strand; B = isolated -bridge; T = 
hydrogen-bonded turn; S = bend; G = 310 helix). Important secondary structures are shown 
in blue (-strands) or red (-helices) against a grey background. Key conserved residues 
lying not necessarily in secondary structures are coloured and marked with an asterisk 
(R/K, in blue), a plus sign (Y/F, in red), or shown in red (aspartic acid preceding central -
helix in effectors). The number of residues required for fully covering the chaperone’s 
interaction surface depends on the conformation of the effector. When the effector is mostly 
in an extended conformation (YopE), the region between the first conserved arginine/lysine 
and the last residue in the last -strand ranges from 31–35 residues. In contrast, the more 
condensed -helical structure of SptP (with a non-interacting, greyed-down -helical 
insertion and a third -helix) allows fitting 71 residues over the SicP chaperone. The 
effector sequence and secondary-structure motifs recognizable in GAPDH are labelled 
accordingly. (C) GAPDH monomer and dimer structure (PDB ID: 1DC5) (Yun et al., 2000) 
shown in cartoons and coloured in rainbow colours. Blue asterisks and plus signs have the 
same meaning as in (A) and (B). N-terminal GAPDH residues predicted to interact with 
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CesT are shown in sticks and CPK colours. In particular, the amino acid stretch 41–51 
forms part of a dimeric interface involving a patch of C-terminal residues (shown also in 
sticks) that is framed by dashed lines. The two symmetric interfaces bury a combined 980 
Å
2
 surface area stabilized by two symmetric sets of 6 hydrogen bonds and 1 salt bridge.  
 
Fig. 5. Immunoblot analysis of GAPDH secretion by several non-pathogenic E.coli strains. 
The indicated strains were grown in DMEM or LB to an OD600 of 0.8 in the presence of 5 
mM IPTG to induce lacZ expression. Aliquots of the culture supernatants (SN) were 
precipitated with TCA and analyzed by Western blot. Whole cell lysates (WL) were 
prepared from the same samples and analyzed in parallel.  
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Table 1. Strains and plasmids used in this study 
 
Strain or 
plasmid 
Genotype or description Source or reference 
E.coli strains   
   XL1Blue recA1 lac endA1 gyrA96 thi hsdR17 supE44 relA1 (F’ proAB lacIq lacZ M15 Tn10) Stratagene 
M15 [pREP4] F
- 
Nal
s
 Str
s
 rif
s
 lac
-
 mtl
-
 recA
-
  [pREP4 Kan
r
] Qiagen 
   E2348/69 Wild type EPEC O127:H6 Str
r
 B.B. Finlay 
   CVD452 E2348/69 escN::aphA3 Jarvis et al. (1995) 
   UMD864 E2348/69 espB Donnenberg et al. (1993) 
escN Non-polar deletion of escN in EPEC E2348/69 Gauthier and Finlay (2003) 
sepD Non-polar deletion of sepD in EPEC E2348/69 Deng et al. (2005) 
cesT Non-polar deletion of cesT in EPEC E2348/69 Abe et al (1999) 
   EcoR12 Human stool isolate Ochman and Selander (1984) 
   EcoR26 Human stool isolate Ochman and Selander (1984) 
   EcoR41 Human stool isolate Ochman and Selander (1984) 
Nissle 1917 Non-pathogenic probiotic isolate (O6:K5:H1) Ardeypharm 
 
Plasmids 
  
pCVD446 BglII  DNA fragment of strain E2348/69 containing escN in pHC79, Ap
r
 Jarvis et al. (1995) 
pGex-GapA pGEX-3x expressing GST-GAPDH, Ap
r
  Egea et al. (2007) 
pQE30 Vector for expression of N-terminal His6-tag proteins,  Ap
r
 Qiagen 
pQE-CesT pQE30 expressing His6-CesT This study 
Table 1
